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Introduction
Antiretroviral therapy (ART) could lower viral burden
and increase CD4+ T cell level in HIV infected patients.
However, the immune reconstitution never completes
therefore an alternative treatment is required. Interest-
ingly, an in vitro expansion of CD4+ T cells from patients
through CD3/28 signaling provided intrinsic control of
viral replication and transfusion of autologous expanded
cells in ART treated patients showed increase in CD4
count. Since functions of CD4+ T cells were different in
each stage of the disease, we determined whether disease
severity has any impact on an in vitro expansion of CD4+
T cells and conducted the experiments to increase CD4
expansion level for being use in clinical trial.
Material and methods
Whole blood samples were collected from both healthy
subjects and different groups of ART treated HIV
infected patients based on CD4 count (<200, 200-500
and > 500 cells/µl). CD4+ T cells were isolated using
immunorosette formation and purified CD4+ T cells
were expanded using anti-CD3/28 coated magnetic beads
for 3 weeks. Fold expansion, viability and purity of anti-
CD3/28 expanded CD4+ T cells were observed. Improve-
ments in fold expansion of CD4+ T cells collected from
patients were tested by a scheduling IL-2 supplemented
culturing method.
Results
The results demonstrated that purified CD4+ T cells
from healthy subjects can be expanded up to 1000-fold
after 3 weeks with high viability (>90%) and high purity
of CD4+ T cells (>95%). Although highly purified
expanded CD4+ T cells can be obtained from patients, a
lower fold expansion was demonstrated when compare
to normal subjects. Furthermore, patients with low CD4
count showed lower fold expansion when compare to
patient with high CD4 count. Finally, the result showed
that a low level IL-2 supplementation after 1 week of
cell expansion can increased the level of cell expansion
for patients.
Conclusions
A large scale in vitro expansion of CD4+ T cells from
HIV infected patients could support an immunotherapy
using autologous transferred of anti-CD3/28 expanded
CD4+ T cells. This method could be used as a new thera-
peutic strategy in HIV infected patients.
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